Chester County News and Community Website
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) recently announced that Science Translational Medicine has published a foundational preclinical article describing the synergy of avasopasem manganese, one of the Company’s selective …
Read MoreWEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI), a clinical stage radiopharmaceutical therapy company focused on therapies for rare diseases, announced the approval of an Investigational New Drug (IND) …
Read MoreWASHINGTON, D.C. — The U.S. Food and Drug Administration recently authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic …
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) has announced interim data from the full patient population (n=42) in its Phase 1/2 clinical trial of avasopasem manganese (GC4419) in combination …
Read More